QuatRx starts Phase II psoriasis study

QuatRx (Ann Arbor, Mich.) started a U.S. Phase II dose-ranging study of its QRX-101 vitamin D analog ointment to treat mild to moderate psoriasis. The double-blind, placebo-controlled trial is expecte...